Company intelligence / Profile preview

DHL Group

Bonn, Germany

Ownership: Private
Employees: ~594000
Development stage: Other

Overview

DHL Group is the world’s largest logistics provider with leading operations in healthcare and life sciences logistics, including specialized cold chain and temperature-controlled services for pharmaceuticals, biopharma, clinical trials, cell and gene therapies, and medical devices. The company is investing €2 billion by 2030 to scale global life sciences logistics, with a focus on next-generation therapies and regulatory-compliant delivery solutions (e.g., cold chain, pharma hubs).

Modalities: Small moleculeBiologicCell therapyGene therapyMedical device
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

SF Express (SF Holding, for supply chain operations in China)Multiple biopharma and medtech organizations globally, including Pfizer and others

Beyond the preview

Go deeper on DHL Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DHL Group.

Explore the full profile